Ignite Creation Date:
2025-12-25 @ 3:08 AM
Ignite Modification Date:
2026-03-02 @ 4:04 PM
Study NCT ID:
NCT02628405
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-01
First Post:
2015-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma
Sponsor:
Academic and Community Cancer Research United
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Recurrent B-Cell Non-Hodgkin Lymphoma | View |
| None | Recurrent Diffuse Large B-Cell Lymphoma | View |
| None | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | View |
| None | Recurrent Transformed Non-Hodgkin Lymphoma | View |
| None | Refractory B-Cell Non-Hodgkin Lymphoma | View |
| None | Refractory Diffuse Large B-Cell Lymphoma | View |
| None | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | View |
| None | Refractory Transformed Non-Hodgkin Lymphoma | View |
Keywords: